<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046198">
  <TermName>LMB-2 immunotoxin</TermName>
  <TermPronunciation>(... IH-myoo-noh-TOK-sin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A toxic substance linked to an antibody that attaches to tumor cells and kills them.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000707819" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;LMB-2 immunotoxin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000707818" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inmunotoxina LMB-2&quot;" language="es" id="_4"/>
  <SpanishTermName>inmunotoxina LMB-2</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia tóxica ligada a un antibiótico que se une a las células tumorales y las destruye.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2007-04-06</DateLastModified>
</GlossaryTerm>
